Lnfluence of insulin on cholesterol removal from macrophages and cholesterol ester uptake by HepG2 cells

European Journal of Clinical Investigation

Volumn 26, Issue 11, 1996, Pages 1004-1010

  Wybranska I ^a   Baczynska E ^a   Cialowicz U ^a   Polus, A ^a   Dembinska Kiec A ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Cholesterol efflux; HDL; HepG2; Insulin; Macrophages

Indexed keywords

HIGH DENSITY LIPOPROTEIN; INSULIN; CHOLESTEROL; CHOLESTEROL ESTER;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CONCENTRATION RESPONSE; DRUG EFFECT; HUMAN; LIPID METABOLISM; LIVER CELL; LIVER CELL CARCINOMA; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CELL CULTURE; METABOLISM; PERITONEUM MACROPHAGE; RAT;

ANIMALS; CHOLESTEROL; CHOLESTEROL ESTERS; HUMANS; INSULIN; MACROPHAGES, PERITONEAL; RATS; TUMOR CELLS, CULTURED;

EID: 0029658031     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1996.2350584.x     Document Type: Article

References (51)

1. Tall A. An overview of reverse cholesterol transport. In: Woodford FP, Duvignon J, Sniderman A, eds. Atherosclerosis X. Proceedings of the 10th International Symposium on Atherosclerosis, Montreal, October 9-14 1994. Amsterdam: Elsevier Science, 1995:725-6.
2. Abbott RD, Wilson WFP, Kannel WB, Castelli WP. High density lipoprotein cholesterol, total cholesterol screening and myocardial infarction: the Framingham Study. Atherosclerosis 1988;8:201-11.
3. Tall AR. Plasma high density lipoproteins: metabolism and relationship to atherosclerosis. J Clin Invest 1990;86:379-84.
4. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 1993;44: 121-131.
5. DeFronzo RA, Ferrannini E. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14: 173-94.
6. Abbott WGH, Lillioja S, Young AA et al. Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population. Diabetes 1987;36: 897-904.
7. Garg A, Helderman JH, Koffler M et al. Relationships between lipoprotein levels and in viro insulin action in normal young white men. Metabolism 1988;37:982-7.
8. Stout RW. Insulin and atheroma: 20 year perspective, Diabetes Care 1990;13:631-41.
9. Zavaroni I, Dall'Aglio E, Alpi O et al. Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and trigliceride. Atherosclerosis 1985;55:259-66.
10. Karhapää P, Malkki M, Laakso M. Isolated low HDL cholesterol. An Insulin Resistant State. Diabetes 1994;43:411-7.
11. Goldsztajn P, Guzdek AO, Kruszelnicka-Kwiatkowska O et al. Hyperinsulinemia inhibits secretion of apo AI more efficiently than secretion of apo AII and apo E. Ger J Gastroentcrol 1996;34 (Suppl. 3):46-8.
12. Wilson-HM, Patel-JC, Russell-D, Skinner-ER. Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease. Clin Chim Acta 1993:220(2):175-87.
13. Stochmal A, Goldsztajn P, Kawecka-Jaszez K et al. Relation between insulinemia and lipoprotein composition in men with primary arterial hypertension with and without hypertriglicerydemia. J Hum Hypertens 1995;9:113-17.
14. Laws A, King AC, Haskell WL, Reaven GM. Relation of lasting plasma insulin concentration to high density lipoprotein cholesterol and triglyceride concentrations in men. Arterioscl Thromb 1991;11:1636-642.
15. Fielding Ch Reverse cholesterol transport. Curr Opin Lipidol 1991;2:376-8.
16. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary artery disease. The Framineham study. Am J Med 1977;62:707-14.
17. Dashti N, Wolfbauer G, Alaupovic P. Binding and degradation of human high density lipoproteins by human hepatoma cell line HepG2. Biochim Biophys Acta 1985;833:100-11.
18. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53.
19. Steibrecher UP, Loughheed M, Kwan WC, Dirks M. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxydation. J Biol Chem 1989;264:15216-23.
20. Craig IF, Via DP, Sherrill BC et al. Incorporation of defined cholesteryl esters into lipoproteins using cholesteryl ester-rich microemulsions. Biol Chem 1982;257:330-5.
21. 14C]-oleate labeled lipoproteins in the rat. Atherosclerosis 1994;106:203-11.
22. Lowry H, Rosebrouh NJ, Farr AL et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
23. Stout RW, Vallance OJ. Insulin and atheroma. Lancet 1969;1: 1078-1080.
24. Bierman EL. Atherogenesis in diabetes. Arterioscler Thromb 1992;12:647-59.
25. Stout RW. The effect of insulin and glucose on sterol synthesis in cultured rat arterial smooth muscle cells. Atherosclerosis 1977; 27:271-8.
26. Young JR, Stout RW. Effect of insulin and glucose in the cells of arterial wall: interaction of insulin with dibutyryl cyclic AMP and low density lipoproteon arterial cells Diabete Metab 1987; 13:301-6.
27. Batena SJ, Avigan J, Schreiner ME. Effect of insulin on sterol and fatty acid synthesis and hydroxymethylglutaryl CoA reductase activity in mamalian cells growth in culture. Proc Natl Acad Sci USA 1974;71:2174-8.
28. Young JR, Stout RW. Effect of insulin and glucose in the cells of arterial wall: interaction of insulin with dibutyryl cyclic AMP and low density lipoproteon arterial cells Diabete Metab 1987; 13:301-6.
29. Oppenheimer MJ, Oram JF, Birman EL. Downregulation of high density lipoprotein receptor activity of cultured fibroblasts by platelet derived growth factor. Arteriosclerosis 1987;7:325-32.
30. Fielding PE, Fielding CJ. Dynamics of lipoprotein transport in the circulatory system. In: Vance DE, Vance JE, eds. Biochemistry of Lipids Lipoproteins and Membranes. Amsterdam: Elsevier, 1991: 427-459.
31. DeLamatre J, Wolfbauer G, Phillips MC, Rothblat GH. Role of apolipoproteins in cellular cholesterol efflux. Biochem Biophys Acta 1986;875:419-28.
32. Mahlberg FH, Rothblat GH. Cellular cholesterol efflux. Role of cell membrane kinetic pools and interaction with apolipoproteins AI, AII and Cs. J Biol Chem 1992;267:4541-50.
33. Oram JF, Mendez AJ, Slotte JP, Johnson TF. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. Arterioscler Thromb 1991;11: 403-14.
34. Slotte JP, Oram JF, Bierman EL. Binding of high density lipoproteins to cell receptors promotes translocation of cholesterol from intracellular membranes to the cell surface. J Biol Chem 1987;262:12904-7.
35. Aviram M, Biermann EL, Oram JF. High density lipoprotein stimulates sterol translocation between intracellular and plasma membrane pools in human monocyte-derived macrophages. J Lipid Res 1989;30:65-76.
36. Theret N, Delbart C, Aguie G, Fruchart JC, Vassaux G, Ailhaud G. Cholesterol efflux from adipose cells is couplet to diacylglycerol production and protein C activation. Biochem Biophys Res Commun 1990;173:1361-8.
37. Mendez AI, Oram JF, Bierman EL. High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts. J. Biol Chem 1991;266:10104-11.
38. Fidge NH, Nestel PI. Identification of apolipoproteins involved in the interaction of human high density lipoprotein 3 with receptors on cultured cells. J Biol Chem 1985;260:3570-5.
39. Graham DL, Oram JF. Identification and characterization of high density lipoprotein binding protein in cell membranes by ligand blotting. J. Biol. Chem. 1987;262:7439-42.
40. Monaco L, Bond MH, Howell E, Cortese RA. A recombinant apoA-1 protein A hybrid reproduces the binding parameters of HDL to its receptor. EMBO J 1987;6:3253-60.
41. Barbaras R, Puchois P, Fruchart JC, Pradines-Figueres, Ailhaud G. Purification of an apolipoprotein A binding protein from mouse adipose cells. Biochem J 1990;269:767-73.
42. Schmitz G, Niemann R, Brennhausen B, Krause R, Assmann G. Regulation of high density lipoprotein receptors in cultured macrophages: role of acyl-CoA: cholesterol acyltransferase. EMBO J 1985;4:2773-9.
43. Brewer HB, Rader D, Fojo S, Hoeg JM. Frontiers in the analysis of HDL structure, function, and metabolism. In Carlson LA, ed. Disorders of HDL. London: Smith-Gordon, 1990: 51-58.
44. Reaven GM. Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension: parallels between human disease and and roden models. Diabetic Care 1991;14:195-202.
45. Taskinen MR. Hyperlipidemia in diabetes. Baillieres Clin Endocrinol Metab 1990;4:743-75.
46. Duell PB, Bierman EL. High glucose levels do not directly impair cellular binding of HDL3 or HDL-mediated efflux of cholesterol from human skin fibroblasts. Acta Diabetol 1991; 28:174-8.
47. Brazg RL, Bierman EL. Insulin excess couteracts the effects of HDL on intracellular sterol accumulation in cultured human skin fibroblasts. Diabetologia 1993;36:942-7.
48. Far'ias RN., Vinals AL., Morero RD. Fusion of negatively charged phospholipid vesicles by insulin: relationship with lipid fluidity. J Biol Chem 1986;261:15508-12.
49. Laakso M, Pyörälä K, Voutilainen AL, Marniemi J. Plasma insulin and serum lipids and lipoproteins in middle aged non-insulin dependent diabetic and non-diabetic subjects. Am J Epidemiol 1986;125:611-21.
50. 2 level in impaired glucose tolerance. Atherosclerosis 1986;60:279-86.
51. Yang Lu-Yin, Kuksis A, Steiner G. Comparison of the effect of hyperinsulinemia on acyl-CoA: cholesterol acyltransferase activity in the liver and intestine of the rat. Atherosclerosis 1994;107: 25-34.